Related Experiment Videos
Clinical features of primary and metastatic hepatic malignancies
S G Pappas1, J S Jeruss, M S Talamonti
1Northwestern University Medical School, Chicago, IL, USA.
Cancer Treatment and Research
|January 5, 2002
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Preoperative portal vein or portal and hepatic vein embolization: DRAGON collaborative group analysis.
The British journal of surgery·2021
Rectus abdominis atrophy after ventral abdominal incisions: midline versus chevron.
Hernia : the journal of hernias and abdominal wall surgery·2017
Dynamic transcription factor activity and networks during ErbB2 breast oncogenesis and targeted therapy.
Integrative biology : quantitative biosciences from nano to macro·2014
Transcription factor networks in invasion-promoting breast carcinoma-associated fibroblasts.
Cancer microenvironment : official journal of the International Cancer Microenvironment Society·2012
Laparoscopic ischemic conditioning of the stomach prior to esophagectomy.
Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2012
Clinical Trials and Translational Advances in Metabolic Targeting.
Cancer treatment and research·2026
Tools and Technologies for Studying Cancer Metabolism.
Cancer treatment and research·2026
Cancer and Immune Cells: A Metabolic Battle in the Tumor Microenvironment.
Cancer treatment and research·2026
Biomarkers of Cancer Metabolism and Therapeutic Response.
Cancer treatment and research·2026
Targeting Metabolism in Cancer Therapy: Inhibitors and Approaches.
Cancer treatment and research·2026
Metabolic Reprogramming in Cancer Stem Cells.
Cancer treatment and research·2026
Follicular lymphoma and the microenvironment: potential targets and biomarkers.
Expert review of clinical immunology·2026
Targeting the HEC1-NEK2 Axis Suppresses DLBCL Progression and Overcomes Vincristine Resistance.
Molecular cancer therapeutics·2026
Bufalin Inhibits Melanoma Progression and Endothelial Angiogenic Phenotypes via AKT Signaling.
Cancer reports (Hoboken, N.J.)·2026